Clinical Trial Update: Rosuvastatin for Preventing Complications in Renal Ablation [Phase 4]

View source ↗

Summary

Phase 4 trial update examining rosuvastatin to prevent complications after renal ablation, sponsored by the University of Rome La Sapienza.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Hypertension

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Arterial Hypertension | Phase 4 | Status: UNKNOWN